Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 2 0043 0624 2244 032--
Entreprise Value (EV)1 2 2833 5024 7044 5354 4454 388
P/E ratio 23,6x42,8x56,1x50,2x42,7x35,7x
Yield 1,24%0,78%0,64%0,74%0,80%0,88%
Capitalization / Revenue 2,80x4,10x5,04x3,94x3,74x3,57x
EV / Revenue 3,19x4,69x5,62x4,44x4,12x3,88x
EV / EBITDA 12,5x19,7x22,5x20,4x18,0x16,2x
Price to Book 7,35x11,9x6,62x6,26x5,77x5,21x
Nbr of stocks (in thousands) 49 55648 03553 73552 735--
Reference price (EUR) 40,463,878,676,576,576,5
Announcement Date 02/04/201902/05/202002/04/2021---
1 EUR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 7177468371 0221 0781 130
EBITDA1 182178209222247272
Operating profit (EBIT)1 140116134136160182
Operating Margin 19,6%15,5%16,0%13,3%14,8%16,1%
Pre-Tax Profit (EBT)1 127109111119139165
Net income1 86,273,773,081,896,3115
Net margin 12,0%9,88%8,71%8,01%8,94%10,2%
EPS2 1,711,491,401,521,792,14
Dividend per Share2 0,500,500,500,570,610,68
Announcement Date 02/04/201902/05/202002/04/2021---
1 EUR in Million
2 EUR
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 243229241270283260
EBITDA1 55,347,050,762,665,857,2
Operating profit (EBIT)1 32,117,526,240,041,033,0
Operating Margin 13,2%7,66%10,9%14,8%14,5%12,7%
Pre-Tax Profit (EBT)1 --24,939,039,033,0
Net income1 --17,227,028,024,0
Net margin --7,13%10,0%9,89%9,23%
EPS2 0,16-0,310,500,500,43
Dividend per Share ------
Announcement Date 02/04/202105/06/202108/05/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 279440480504413357
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,53x2,47x2,30x2,26x1,67x1,31x
Free Cash Flow1 96,095,894,989,6110130
ROE (Net Profit / Equities) 34,4%28,3%21,9%14,8%16,7%17,7%
Shareholders' equity1 251260333554578651
ROA (Net Profit / Asset) 10,3%7,69%7,50%5,77%6,50%7,62%
Assets1 8379589731 4171 4811 513
Book Value Per Share2 5,515,3511,912,213,314,7
Cash Flow per Share2 2,732,242,902,822,893,31
Capex1 40,443,755,170,765,366,9
Capex / Sales 5,63%5,86%6,58%6,92%6,06%5,92%
Announcement Date 02/04/201902/05/202002/04/2021---
1 EUR in Million
2 EUR
Key data
Capitalization (EUR) 4 031 590 750
Capitalization (USD) 4 731 358 702
Net sales (EUR) 837 259 000
Net sales (USD) 982 782 987
Number of employees 8 030
Sales / Employee (EUR) 104 266
Sales / Employee (USD) 122 389
Free-Float 48,8%
Free-Float capitalization (EUR) 1 968 105 185
Free-Float capitalization (USD) 2 309 711 519
Avg. Exchange 20 sessions (EUR) 5 511 725
Avg. Exchange 20 sessions (USD) 6 469 718
Average Daily Capital Traded 0,14%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA